Hyperpigmentation on faces is a highly anxiety-producing symptom, especially for women from the aspect of beauty. We previously reported the skin whitening effect of linoleic acid (LA), 1,2) the mechanism of the whitening effect involving a decrease in tyrosinase level by LA, 3) and clinical trials of liposomal LA for skin hyperpigmentary disorders, such as melasma.
Hyperpigmentation on faces is a highly anxiety-producing symptom, especially for women from the aspect of beauty. We previously reported the skin whitening effect of linoleic acid (LA), 1, 2) the mechanism of the whitening effect involving a decrease in tyrosinase level by LA, 3) and clinical trials of liposomal LA for skin hyperpigmentary disorders, such as melasma. 4) Although these reports described the whitening effect of LA in transdermal application, and the stabilization of LA by liposomal formulation, it was not confirmed whether LA encapsulated in liposomes enhanced the skin whitening effect. There have been number of reports that describe transdermal application using liposomes on cutaneous absorption, [5] [6] [7] on the transdermal delivey of encapsulated drugs 8) and on effective interaction of dermal skin cells with liposomes containing drugs in liposomes. [9] [10] [11] The synergistic effect of liposomes on active reagents for whitening via transdermal application was also reported. 12) Compared to those reagents previously reported, LA is not only effective in whitening but also quite safe. 13) Although there are many examples of the transdermal applications of liposomal formulations, little is known about the enhancement of drug efficacy by liposomalization. From this point of view, we were interested in the possible enhancement of LA's whitening activity by encapsulating it in liposomes. The present study clearly demonstrated that LA encapsulation in liposomes significantly enhanced it's whitening efficacy by transdermal application for UV-induced hyperpigmented dorsal skin of brownish guinea pigs. We also observed enhanced whitening efficacy by liposomalization of LA in UV-induced hyperpigmented human skin.
MATERIALS AND METHODS
Whitening Assay UVB-induced hyperpigmentation was elicited on the backs of brownish guinea pigs weighing about 600 g each (Saitama Experimental Animal Supply Co., Japan) using a modification of the method reported by Imokawa et al. 14) Guinea pigs were gently tethered, and four separate areas (2.5 cmϫ2 cm) on the back of each animal were exposed to UVB radiation (ToRex FL20S-E-30/DMR, Toshiba, Japan) three times a week (every other day) for two consecutive weeks. The UVB intensity was 2 mW/cm 2 , and total energy dose was 1 J/cm 2 per exposure. Groups of six or more animals were used in each experiment. The animals were then left for an additional week to allow the UVBinduced hyperpigmentation to stabilize. Test samples were then topically applied daily to the hyperpigmented areas (0.01 ml/cm 2 ) five times per week for 3 successive weeks. The degree of pigmentation was assessed as the L-value measured with a chromameter (CR-200, Minolta, Japan) once every week from the beginning of sample application. The animals were cared for according to the guidelines for the Care and Use of Laboratory Animals of the University of Shizuoka.
In the case of human skin assay, persons being tested were 6 healthy men in their 20 s or 30 s. After obtaining informed consents from the volunteers, UVB-induced hyperpigmentation was elicited on the inside skin of the upper arm. Four separate areas (1.2 cmϫ1.2 cm) on the inside skin of each upper arm were exposed to UVB radiation (ToRex FL20S-E-30/DMR) from 5 to 7 times a week for two consecutive weeks until substantial hyperpigmentation was achieved in each person. The UVB intensity was 1 mW/cm 2 , and the total energy dose was 1.2-fold a minimal erythema dose (MED) per day for each person. Sample application was started 2 d after the final UVB radiation. Test samples were then topically applied daily to the hyperpigmented areas (0.01 ml/cm 2 ) 2 times every day for 2 successive months. The degree of pigmentation was assessed once every week from the beginning of sample application by the same method used for the test animals.
Preparation of Liposomal LA LA used for all samples
Skin Whitening Effect of Linoleic Acid Is Enhanced by Liposomal Formulations
was Extralinoleic 90 purchased from NOF Co. (Japan). Liposomal Extralinoleic 90 was prepared by Coletica (France). In brief, liposomes composed of unhydrogenated soybean phospholipids with more than 90% phosphatidylcholine (Phospholipon 90, Nattermann Phospholipids GmbH, Germany) and LA were prepared with a high-pressure homogenizer. The obtained liposomal suspension was mixed with a hydrophilic polymer reagent, Carbopol 940 (Nikko Chemicals Co., Ltd., Japan). This hydrogel (pH 6.6) was used to stabilize liposomes by means of giving viscosity to the formulation. The final concentration of LA was 0.05% or 0.1% (w/w) in terms of LA, and the final concentration of phospholipid was 0.4% (w/w) containing 0.01% a-tocopherol. Two other types of sample were prepared as a control. One was an ethanol solution containing 0.1% (w/v) LA, the other was hydrogel Carbopol 940 containing LA with a small amount of polyoxyethylene hydrogenated castor oil, Nikkol HCO-60 (Nikko Chemicals Co., Ltd., Japan) for the solubilization of LA. Final concentrations of LA in this type of hydrophilic gel were 0.1, 3.0 and 10.0% (w/w), respectively, and their pH was adjusted to 6.6.
Characterization of Liposomes
The size distribution of liposomes was determined by quasi-elastic light scattering analysis 15) employing a submicron particle sizer (NICOMP 370, Particle sizing systems, U.S.A.). The mean size of the liposomes was 220Ϯ110 nm. Morphology of the liposomes was monitored with a transmission electron microscope (JEM-100SX, JEOL, Japan) operating at 80 kV after the sample was negatively stained with 1.0% (w/v) phosphotungstate solution (SIGMA, U.S.A.). 16) As shown in Fig. 1 , the electron micrograph showed that the liposomes were multilamellar vesicles.
Statistical Analysis Variance in a group was evaluated by the F-test, and differences in mean increase of L value were evaluated by Student's t-test.
RESULTS

Assessment of Whitening Effect by Animal Assays
At first, the whitening effect LA in the liposomal formulation was examined in comparison with that in ethanol or in hydrogel by the use of UVB-induced hyperpigmented skin. Figure  2 shows a typical skin sample after treatment with LA in ethanol and in liposomes. Hydrogel containing liposomal LA effectively lightened the skin. Quantitative evaluation of whitening was done by determining the changing rate of Lvalues 1) after 3 weeks of daily topical applications of samples. As shown in Fig. 3 , the hyperpigmentation was lightened more effectively when liposomal LA was applied, than with the application of LA in ethanol or in hydrogel. Interestingly, control liposomes, namely hydrogel containing liposomes without LA, also caused partial lightning of the skin. The backs of brownish guinea pigs were exposed to UVB radiation three times a week for two consecutive weeks to prepare hyperpigmented skin (upper photograph), as described in Materials and Methods. After one week, topical application of LA in ethanol (left side of the lower photograph), or liposomal LA (right side) was performed daily to the hyperpigmented areas five times per week for 3 successive weeks. The photograph shows typical data, although similar results were observed in the other 5 animals. 
Assessment of Whitening Effect by Human Assay
Depigmentation with liposomal LA on the brachium was enforced by human trial using a 0.1% concentration of LA in liposomes, and a non-liposomal formulation containing 3.0% and 10.0% LA was shown in Fig. 4a . The liposomal formulation containing 0.1% LA demonstrated a marked decrease in hyperpigmentation compared with the non-liposomal formulation containing 3.0% LA, and the extent of hyperpigmentation decrease by the liposomal LA (0.1%) was nearly equal to the non-liposomal formulation containing 10.0% LA, as shown in Fig. 4b . The same result was observed as that shown in Fig. 5 , in which the extent of whitening appeared to be nearly equal in both formulations at different LA concentrations, and the whitening levels were higher than the other two controls. The photograph in Fig. 5 indicates again that the whitening effects of liposomal formulation containing 0.1% LA is nearly equal to that of the non-liposomal formulation containing 10.0% LA, and the test was whiter than the other two control areas, which had been applied with 3.0% LA or no treatment.
DISCUSSION
A number of studies on transdermal application indicate the enhanced penetration of medicinal reagents. Transdermal application of LA was reported in terms of its cutaneous distribution, and it acted as a transdermal absorption-promoting agent. 17, 18) In these studies on the topical application of LA, it was observed that the stratum corneum in the epidermis retained LA for 24 h after a single application, and its concentration in the dermis increased with time. However, the mechanism by which LA enhances the permeation of drugs through the skin is not clearly understood. In contrast, some unsaturated fatty acids including LA are known to act as skin irritants. 19, 20) Therefore, it is an important challenge to reduce the minimum effective LA concentration for the whitening of skin in the cosmetics field. We previously reported that LA has an ability to reduce hyperpigmentation of skin. 1, 21) In those studies, LA was applied as an ethanol solution, and its whitening effect was not compared with other formulations. On the other hand, liposomal LA has been used in clinical tests for melasma 4) : liposomes were used for the purpose of protecting unstable LA from oxidation. There seems to be no report so far for studying the enhancement effect of liposomalization on LA-induced skin whitening.
In the present study, we observed the effective whitening of hyperpigmented skin by the use of liposomal LA (0.1%). This result suggests that basal formulations influence the whitening effect of LA, and that a liposomal formulation is superior to ethanol solution or a hydrogel formulation in which LA may be present as micelles. The encapsulation of LA in liposomes enables LA to produce a whitening effect at a lower concentration. Here, it should be noted that liposomes alone, without LA, showed whitening activity to some extent. The liposomal formulation was composed of various components, such as phospholipids with polyunsaturated fatty acyl chains, that possibily influenced the whitening effect of liposomal LA. 1) However, the effect of liposomal LA was not explained by the additive effect of control liposomes (empty liposomes) and LA in hydrogel (LA alone). Therefore, liposomal formulation is important for obtaining the enhanced whitening effect of LA. Figure 4 indicates that human skin whitening increases time-dependently with liposomal LA (0.1%), producing higher activity in L-value. This is significantly higher than treatment with a non-liposomal gel formulation containing 3.0% LA, and is nearly equal to a non-liposomal gel formulation containing 10.0% LA (Fig. 4b) . Thus, only one hundredth of LA is enough to achieve the same extent of skin whitening level compared with a non-liposomal gel formulation having 10.0% LA, suggesting the potential use of liposomal LA as a base for practical whitening cosmetics for human. Since it is known that LA suppresses melanin synthesis inside melanocytes, 3) the present study suggests that liposomes might enhance the incorporation of LA into melanocytes. However, the mechanism by which liposomes enhance the whitening effect of LA is unknown at present.
In conclusion, we have demonstrated that liposomal LA is significantly more effective than non-liposomal formulations in reducing hyperpigmentation of both guinea pig and human skin. These experimental results can be directly correlated to the efficiency of its practical application to skin whitening. Although further investigation should be needed to disclose the mechanism of whitening enhancing effect by liposomal formulation, it should be emphasized that, in general, liposomes not only play an important role as a drug delivery vehicle for skin tissue targeting, but also have a potential role in the transdermal application of cosmetics. We are of the opinion that liposomes are one of the efficacious transdermal application tools for skin tissue targeting, for instance, in drugs for external use and cosmetics.
